Drug Detail

Information about Hu5F9-G4

Generic Name
IND
 Hu5F9-G4
Brand Name (US)
Manufacturer
 Stanford University
Drug Type
Delivery
Approval Status
 Phase 1
Indications
Overall Strategy
Strategy
 Immunotherapy
Drug Category
 CD47 inhibitor

Links

 

 CureSearch: Developing CD47 Antibody Therapy
   

 

 NCI Drug Dictionary
   

 

 Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential.
   

 

 Forty Seven, Inc. science of CD47 inhibition
   

Trials of this drug

  

 Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody
   

Trial results

Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed